114 related articles for article (PubMed ID: 11753653)
1. Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis.
Gentile M; Ahnström M; Schön F; Wingren S
Oncogene; 2001 Nov; 20(53):7753-60. PubMed ID: 11753653
[TBL] [Abstract][Full Text] [Related]
2. Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.
Sinha S; Singh RK; Bhattacharya N; Mukherjee N; Ghosh S; Alam N; Roy A; Roychoudhury S; Panda CK
Mol Oncol; 2011 Oct; 5(5):454-64. PubMed ID: 21803008
[TBL] [Abstract][Full Text] [Related]
3. The p53-inducible gene EI24/PIG8 localizes to human chromosome 11q23 and the proximal region of mouse chromosome 9.
Gu Z; Gilbert DJ; Valentine VA; Jenkins NA; Copeland NG; Zambetti GP
Cytogenet Cell Genet; 2000; 89(3-4):230-3. PubMed ID: 10965130
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation.
Allinen M; Peri L; Kujala S; Lahti-Domenici J; Outila K; Karppinen SM; Launonen V; Winqvist R
Genes Chromosomes Cancer; 2002 Aug; 34(4):384-9. PubMed ID: 12112527
[TBL] [Abstract][Full Text] [Related]
5. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23.
Monaco C; Negrini M; Sozzi G; Veronese ML; Vorechovsky I; Godwin AK; Croce CM
Genomics; 1997 Dec; 46(2):217-22. PubMed ID: 9417908
[TBL] [Abstract][Full Text] [Related]
7. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.
Lu ML; Wikman F; Orntoft TF; Charytonowicz E; Rabbani F; Zhang Z; Dalbagni G; Pohar KS; Yu G; Cordon-Cardo C
Clin Cancer Res; 2002 Jan; 8(1):171-9. PubMed ID: 11801555
[TBL] [Abstract][Full Text] [Related]
8. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
9. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
Kalla C; Scheuermann MO; Kube I; Schlotter M; Mertens D; Döhner H; Stilgenbauer S; Lichter P
Eur J Cancer; 2007 May; 43(8):1328-35. PubMed ID: 17449237
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis factor EI24/PIG8 is a novel endoplasmic reticulum-localized Bcl-2-binding protein which is associated with suppression of breast cancer invasiveness.
Zhao X; Ayer RE; Davis SL; Ames SJ; Florence B; Torchinsky C; Liou JS; Shen L; Spanjaard RA
Cancer Res; 2005 Mar; 65(6):2125-9. PubMed ID: 15781622
[TBL] [Abstract][Full Text] [Related]
13. p53 mutations and expression in breast carcinoma in situ.
Lukas J; Niu N; Press MF
Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
[TBL] [Abstract][Full Text] [Related]
14. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
15. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of five candidate genes in familial breast cancer.
Marsh A; Healey S; Lewis A; Spurdle AB; Kedda MA; Khanna KK; ; Mann GJ; Pupo GM; Lakhani SR; Chenevix-Trench G
Breast Cancer Res Treat; 2007 Nov; 105(3):377-89. PubMed ID: 17187232
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers.
Takagi Y; Futamura M; Yamaguchi K; Aoki S; Takahashi T; Saji S
Gut; 2000 Aug; 47(2):268-71. PubMed ID: 10896920
[TBL] [Abstract][Full Text] [Related]
18. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.
Calin GA; di Iasio MG; Caprini E; Vorechovsky I; Natali PG; Sozzi G; Croce CM; Barbanti-Brodano G; Russo G; Negrini M
Oncogene; 2000 Feb; 19(9):1191-5. PubMed ID: 10713707
[TBL] [Abstract][Full Text] [Related]
19. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
